MedPath

Results after the surgical therapy of the symptomatic prostate adenoma in unselected patients with two laser systems

Conditions
N40
Hyperplasia of prostate
Registration Number
DRKS00024736
Lead Sponsor
Krankenhaus Reinbek St. Adolf Stift
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
Male
Target Recruitment
500
Inclusion Criteria

Indication for transurethral intervention for the treatment of symptomatic prostatic hyperplasia according to the DGU and EAU guidelines.

Exclusion Criteria

Presence of a relevant prostate cancer.

Study & Design

Study Type
observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Morbidity and quality of results after transurethral laser-assisted therapy of symptomatic prostatic hyperplasia.
Secondary Outcome Measures
NameTimeMethod
Identification of risk factors for an unfavorable post-interventional outcome.
© Copyright 2025. All Rights Reserved by MedPath